Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19757 | 427 | 47.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SECRETION INHIBITION | Author keyword | 6 | 80% | 1% | 4 |
2 | RNF13 | Author keyword | 4 | 67% | 1% | 4 |
3 | PROTEASE ASSOCIATED DOMAIN | Author keyword | 4 | 75% | 1% | 3 |
4 | GRAIL | Author keyword | 2 | 25% | 1% | 6 |
5 | ODE MODEL | Author keyword | 2 | 25% | 1% | 6 |
6 | ANERGY INDUCTION | Author keyword | 1 | 100% | 0% | 2 |
7 | QUORUM THRESHOLD | Author keyword | 1 | 100% | 0% | 2 |
8 | GOLIATH | Author keyword | 1 | 40% | 0% | 2 |
9 | 6C10 | Author keyword | 1 | 50% | 0% | 1 |
10 | AMINOPEPTIDASE Y | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SECRETION INHIBITION | 6 | 80% | 1% | 4 | Search SECRETION+INHIBITION | Search SECRETION+INHIBITION |
2 | RNF13 | 4 | 67% | 1% | 4 | Search RNF13 | Search RNF13 |
3 | PROTEASE ASSOCIATED DOMAIN | 4 | 75% | 1% | 3 | Search PROTEASE+ASSOCIATED+DOMAIN | Search PROTEASE+ASSOCIATED+DOMAIN |
4 | GRAIL | 2 | 25% | 1% | 6 | Search GRAIL | Search GRAIL |
5 | ODE MODEL | 2 | 25% | 1% | 6 | Search ODE+MODEL | Search ODE+MODEL |
6 | ANERGY INDUCTION | 1 | 100% | 0% | 2 | Search ANERGY+INDUCTION | Search ANERGY+INDUCTION |
7 | QUORUM THRESHOLD | 1 | 100% | 0% | 2 | Search QUORUM+THRESHOLD | Search QUORUM+THRESHOLD |
8 | GOLIATH | 1 | 40% | 0% | 2 | Search GOLIATH | Search GOLIATH |
9 | 6C10 | 1 | 50% | 0% | 1 | Search 6C10 | Search 6C10 |
10 | AMINOPEPTIDASE Y | 1 | 50% | 0% | 1 | Search AMINOPEPTIDASE+Y | Search AMINOPEPTIDASE+Y |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLONAL ANERGY | 19 | 16% | 25% | 107 |
2 | QUORUM GROWTH THRESHOLDS | 11 | 100% | 1% | 6 |
3 | CBL B | 7 | 20% | 7% | 32 |
4 | IL 2 GENE | 5 | 17% | 6% | 27 |
5 | V BETA 81 TRANSGENIC MICE | 5 | 55% | 1% | 6 |
6 | GROWTH RESPONSE GENE 2 | 3 | 100% | 1% | 3 |
7 | T CELL ANERGY | 3 | 23% | 3% | 12 |
8 | EGR 2 | 2 | 50% | 1% | 3 |
9 | ANERGY INDUCTION | 2 | 22% | 2% | 8 |
10 | ANCHORED GROWTH FACTOR | 2 | 43% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
T cell anergy | 2003 | 680 | 115 | 45% |
New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting | 2009 | 64 | 89 | 37% |
Molecular regulation of T-cell anergy | 2008 | 40 | 50 | 54% |
Molecular mechanisms of CD4(+) T-cell anergy | 2007 | 65 | 102 | 36% |
T cell clonal energy | 1997 | 196 | 42 | 40% |
GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness | 2011 | 9 | 61 | 59% |
Molecular mechanisms for adaptive tolerance and other T cell anergy models | 2007 | 42 | 93 | 40% |
mTOR at the crossroads of T cell proliferation and tolerance | 2007 | 49 | 127 | 32% |
Mechanisms maintaining peripheral tolerance | 2010 | 132 | 86 | 12% |
Molecular mechanisms of T-cell tolerance | 2011 | 16 | 117 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHILDRENS HOSP PHILADELPHIA PATHOL MED | 1 | 50% | 0.2% | 1 |
2 | INSERM CJF 9608 | 1 | 50% | 0.2% | 1 |
3 | ONCOL IMMUNOL HEMATOPOIESIS | 1 | 50% | 0.2% | 1 |
4 | UMR 8104 HEMATOL | 1 | 50% | 0.2% | 1 |
5 | ESCOLA SUPER ESTUDOS IND GESTAO | 1 | 17% | 0.7% | 3 |
6 | BICMS | 0 | 33% | 0.2% | 1 |
7 | INVEST MED MED | 0 | 33% | 0.2% | 1 |
8 | UMR49 | 0 | 33% | 0.2% | 1 |
9 | BIOINFORMAT GENE DISCOVERY GRP | 0 | 25% | 0.2% | 1 |
10 | CELL SYST INITIAT | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215275 | MULTI ORGAN TRANSPLANTAT PROGRAM//TROGOCYTOSIS//CLINICIAN SCIENTIST TRAINING PROGRAM |
2 | 0.0000190101 | CBL B//CBL//CIN85 |
3 | 0.0000183510 | CD28//CD80//B7 |
4 | 0.0000171689 | CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION |
5 | 0.0000113167 | T CELL METABOLISM//UAB MITOCHONDRIAL MED//BZ 423 |
6 | 0.0000099347 | FOXP3//REGULATORY T CELLS//REGULATORY T CELL |
7 | 0.0000098845 | ORAL TOLERANCE//EPICUTANEOUS IMMUNIZATION//MUCOSAL TOLERANCE |
8 | 0.0000088246 | PEPTIDE MHC//PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX//PROT CRYSTALLOG UNIT |
9 | 0.0000083248 | INTERDISCIPLINARY PROGRAM IMMUNOL//INTEGRATED IMMUNOL VACCINE//T CELL COMPETITION |
10 | 0.0000082297 | WWP1//SMURF1//CKIP 1 |